The reality of heart failure in Latin America

EA Bocchi, A Arias, H Verdejo, M Diez, E Gómez… - Journal of the American …, 2013 - jacc.org
Heart failure (HF) data in Latin America (LA) were reviewed to guide health service planning
in the prevention and treatment of HF. The HF epidemiology and the adequacy of relevant …

Heart failure in South America

EA Bocchi - Current cardiology reviews, 2013 - ingentaconnect.com
Continued assessment of temporal trends in mortality and epidemiology of specific heart
failure in South America is needed to provide a scientific basis for rational allocation of the …

III Diretriz brasileira de insuficiência cardíaca crônica

EA Bocchi, FGM Braga, SMA Ferreira… - Arquivos Brasileiros …, 2009 - SciELO Brasil
O objetivo desta Diretriz é servir de apoio e auxiliar os médicos nas decisões referentes aos
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …

Cardiomyopathy, adult valve disease and heart failure in South America

EA Bocchi, G Guimarães, F Tarasoutshi, G Spina… - Heart, 2009 - heart.bmj.com
Continued assessment of temporal trends in mortality and epidemiology of specific
cardiovascular diseases in South America is needed to provide a scientific basis for rational …

Qualidade de vida em foco

R Monteiro, DM Braile, R Brandau… - Brazilian Journal of …, 2010 - SciELO Brasil
SciELO - Brasil - Qualidade de vida em foco Qualidade de vida em foco Acessibilidade /
Reportar erro Brasil Lista alfabética de periódicos Lista temática de periódicos Busca Métricas …

[HTML][HTML] I Diretriz brasileira de miocardites e pericardites

MW Montera, ET Mesquita… - Arquivos Brasileiros …, 2013 - SciELO Brasil
Os relatos de estudos de autópsias estimam uma incidência entre 0, 2 e 12% dependendo
da população estudada 1, 2. O ensaio clínico Myocarditis Treatment Trial relatou uma …

[HTML][HTML] Levosimendan in critical illness: a literature review

C Pierrakos, D Velissaris, F Franchi… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Levosimendan, the active enantiomer of simendan, is a calcium sensitizer developed for
treatment of decompensated heart failure, exerts its effects independently of the beta …

Effects of levosimendan on the energy balance: preclinical and clinical evidence

MS Nieminen, P Pollesello, G Vajda… - Journal of …, 2009 - journals.lww.com
Levosimendan is a novel inodilator agent, which enhances myocardial performance without
substantial changes in oxygen consumption. The combination of positive inotropic and …

I Brazilian guidelines on myocarditis and pericarditis

MW Montera, ET Mesquita… - Arquivos brasileiros de …, 2013 - SciELO Brasil
The true incidence of myocarditis is difficult to estimate due to factors such as diversified
clinical presentation, the continued infrequency of endomyocardial biopsy (EMB) …

Levosimendan in acute decompensated heart failure: systematic review and meta-analysis

RA Ribeiro, LEP Rohde, CA Polanczyk - Arquivos brasileiros de …, 2010 - SciELO Brasil
Background: Congestive heart failure (CHF) is a rather prevalent condition with a high
mortality rate. Levosimendan is one among the new drugs that have been tested for its …